DGX
Quest Diagnostics, Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$246.48
−0.39%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$246.28
From 52W high−0.39%
Volume1.91M
Market cap$27.20B
P/E (TTM)25.8x
P/S (TTM)2.4x
Div yield1.35%
Key dataSep 18, 2026
Open
$246.28
From 52W high
−0.39%
Volume
1.91M
Market cap
$27.20B
ValuationView details →
P/E (Fwd)
21.5x
EV/EBITDA
16.6x
P/E (TTM)
25.8x
RSI (14)
64.2
MomentumView details →
1D Return
−0.39%
YTD Return
+42.43%
SummaryUpdated Jun 1, 2026
Quest Diagnostics Incorporated (NYSE:DGX) is one of the largest clinical laboratory testing companies in the United States, founded in 1967 and headquartered in Secaucus, New Jersey. The company went public in 1996 and has grown through both organic expansion and strategic acquisitions to become a dominant player in the diagnostic testing industry. Quest operates a nationwide network of laboratories and patient service centers, providing essential diagnostic information services to healthcare providers, patients, and other stakeholders across the healthcare ecosystem.
Similar companies
Latest newsMore news →